Emergent BioSolutions' Phase III trial of SARS-CoV-2 Immune Globulin Intravenous (Human) (COVID-HIG) to treat hospitalized patients with COVID-19 showed that the addition of the treatment to...
The 2021 AGBT meeting went virtual, denying attendees the usual beachside venue, but it still delivered the hottest advances in spatial transcriptomics, epigenomics, and COVID-19. The...
New model captures glycan molecules whose motions shield much of the spike from immune defenses Credit: Mateusz Sikora, Sören von Bülow, Florian E. C. Blanc, Michael...
Fauci Rejects CDC Director's "Impending Doom" View Of Pandemic The old flip-flopper is back. Having supported CDC Director Walensky's dystopian outlook for America unless we all...
A new imaging technology called ‘high parameter imaging mass cytometry’ developed through a collaborative effort reveals hitherto unseen details in lung pathology due to several infectious...
Pfizer and BioNTech on March 31 announced data from a Phase III study which showed 100 percent efficacy and robust antibody responses in patients ages 12-15 years...
The US lags in testing coronavirus samples from COVID-19 patients, which can help track the spread of the virus and the emergence of new variants. But...
Relief Therapeutics Holding AG (OTC: RLFTF) is making a powerful run northbound after NeuroRx reported ZYESAMI™ met the primary endpoint in its Phase 2b/3 trial* for...
Futures Flat, Yields Rise Ahead Of Biden Multi-Trillion Infrastructure Plan US index futures were little changed and global stocks treaded water on Wednesday as Treasury yields...
The US lags in testing coronavirus samples from COVID-19 patients, which can help track the spread of the virus and the emergence of new variants. But...
A critical component of the immune system known as T cells that respond to fight infection from the original version of the novel coronavirus appear to...
NIAID research suggests protective effects of vaccination remain intact Credit: NIAID WHAT: When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern...
Two antibodies targeting different parts of the COVID-19 virus spike protein, from Eli Lilly and GlaxoSmithKline/Vir Biotech, can The post Lilly and GSK/Vir antibody pairing offers...
The Great Unvaxxed - A 'Fictional' Look At What Lies Ahead Authored by TE Creus via Off-Guardian.org, The vaccine was a resounding success. Yes, there had...
Credit: Pixabay/Yen Strandqvist, Chalmers University of Technology Artificial Intelligence is now capable of generating novel, functionally active proteins, thanks to recently published work by researchers from...
Why Are We Vaccinating Children Against COVID-19? Authored by Paul Alexander via The American Institute for Economic Research, The acute focus in this writing is on...
Researchers identify signatures of immune dysfunction that are shared in aging and chronic viral infections of HIV and Hepatitis C Credit: Dr. David Furman Research from...
Credit: Images courtesy of André Rendeiro. A team led by investigators at Weill Cornell Medicine and NewYork-Presbyterian has used advanced technology and analytics to map, at...
Antibody treatments from Eli Lilly and Vir Biotechnology reduced viral load in low-risk Covid-19 patients, results from a mid-stage trial showed on March 29.
The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab as a monotherapy just four months after it received FDA emergency use authorization,...
The EU looks set to approve emergency use of a third antibody therapy for COVID-19
Credit: UPMC PITTSBURGH, March 26, 2021 – As evidence mounts supporting the use of monoclonal antibody treatment to reduce hospitalizations and deaths from COVID-19, UPMC and...
The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab as a monotherapy just four months after it received FDA emergency use authorization,...
Active ingredient inhibits infection with so-called pseudoviruses in the test tube, as shown by study at the University of Bonn Credit: © Stefan Breuers/LIMES Scientists at...
U.S. college students vaccinated with Moderna Inc.’s COVID-19 vaccine will be part of a new study to test mRNA-1273's effectiveness in curbing the spread of the...
GSK and Vir Biotechnology filed an application to U.S. regulators for emergency use authorization of their antibody therapy to treat early-stage Covid-19 infections, the drugmakers said...
Researchers in the US are the first to study how pregnant and breast-feeding women are responding to the vaccines. The results are promising
In announcing the halt this week, the U.S. Office of the Assistant Secretary for Preparedness and Response (ASPR) said it will continue to distribute bamlanivimab in...
Candidate: MV-014-212 Category: VAX Type: Intranasal live-attenuated chimeric vaccine candidate against SARS-CoV-2, developed through the company’s the company’s AttenuBlock™ platform, which applies rational and precise codon deoptimization...
What to make of markets today? Everything is both up and down. The major stock indexes are showing strong gains for the past year, but have...